Neko Health Adds Body Composition Tracking and Wearables Integration

The integration of body composition tracking allows Neko’s imaging technology to quantify visceral fat—the harmful adipose tissue surrounding internal organs—without the use of X-ray radiation. Because this fat is often missed by standard BMI metrics and routine physicals, clinicians can now identify early markers for insulin resistance and metabolic disease. By combining these findings with longitudinal data from Apple Health, such as sleep patterns and heart rate variability, the company aims to move beyond isolated metrics toward a comprehensive view of patient physiology.

Founder and CEO Hjalmar Nilsonne described the update as a move to redesign the healthcare system from the ground up, emphasizing that the company intends to iterate on its hardware and software capabilities annually. Chief Medical Officer Dr. Sunita Mishra noted that pairing metabolic data with a year’s worth of activity tracking transforms individual data points into a narrative, providing a clearer path for early clinical intervention. These updates follow the company's recent expansion across the UK and its planned entry into the United States market later this year.